Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:9
|
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [21] Preoperative Portal Vein Embolization and Surgical Resection in Patients with Hepatocellular Carcinoma and Small Future Liver Remnant Volume: Comparison with Transarterial Chemoembolization
    Dong Dae Seo
    Han Chu Lee
    Myoung Kuk Jang
    Hyun Ju Min
    Kang Mo Kim
    Young Suk Lim
    Young-Hwa Chung
    Yung Sang Lee
    Dong Jin Suh
    Gi-Young Ko
    Young-Joo Lee
    Sung-Gyu Lee
    Annals of Surgical Oncology, 2007, 14 : 3501 - 3509
  • [22] Resection of hepatocellular carcinoma in cirrhotic patients: laparoscopic versus open resection
    Khalil, Ahmed
    Aboelnaga, Mohamed
    Omar, Wael
    EGYPTIAN JOURNAL OF SURGERY, 2018, 37 (03): : 375 - 383
  • [23] Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma
    Zhao, Yin-Nong
    Zhang, Yong-Quan
    Ye, Jia-Zhou
    Liu, Xing
    Yang, Hong-Zhi
    Cong, Feng-Yun
    Xiang, Bang-De
    Wu, Fei-Xiang
    Ma, Liang
    Li, Le-Qun
    Ye, Hai-Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3813 - 3819
  • [24] Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma
    Otto, G.
    Heise, M.
    Moench, C.
    Herber, S.
    Bittinger, F.
    Schuchmann, M.
    Hoppe-Lotichius, M.
    Pitton, M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (02) : 537 - 539
  • [25] A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma
    Lin, Nanping
    Wang, Lei
    Huang, Qizhen
    Zhou, Weiping
    Liu, Xiaolong
    Liu, Jingfeng
    PLOS ONE, 2022, 17 (10):
  • [26] Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
    Chen, Shuling
    Jin, Huilin
    Dai, Zihao
    Wei, Mengchao
    Xiao, Han
    Su, Tianhong
    Li, Bin
    Liu, Xin
    Wang, Yu
    Li, Jiaping
    Shen, Shunli
    Zhou, Qi
    Peng, Baogang
    Peng, Zhenwei
    Peng, Sui
    CANCER MEDICINE, 2019, 8 (04): : 1530 - 1539
  • [27] Liver scintigraphy is useful for selecting candidates for preoperative transarterial chemoembolization among patients with hepatocellular carcinoma and chronic liver disease
    Nakano, H
    Yoshida, K
    Takeuchi, S
    Kumada, K
    Yamaguchi, M
    Jaeck, D
    AMERICAN JOURNAL OF SURGERY, 1999, 178 (05): : 385 - 389
  • [28] Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
    Jeon, Mi Young
    Kim, Hye Soo
    Lim, Tae Seop
    Han, Dai Hoon
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Choi, Gi Hong
    Choi, Jin Sub
    Han, Kwang-Hyub
    Kim, Seung Up
    PLOS ONE, 2019, 14 (04):
  • [29] LIVER RESECTION VERSUS TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Zhu, Wanjie
    Chen, Shuling
    Jin, Huilin
    GUT, 2019, 68 : A128 - A128
  • [30] Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study
    Fu, Sirui
    Wei, Jingwei
    Zhang, Jie
    Dong, Di
    Song, Jiangdian
    Li, Yong
    Duan, Chongyang
    Zhang, Shuaitong
    Li, Xiaoqun
    Gu, Dongsheng
    Chen, Xudong
    Hao, Xiaohan
    He, Xiaofeng
    Yan, Jianfeng
    Liu, Zhenyu
    Tian, Jie
    Lu, Ligong
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10